ADMA Biologics Inc (ADMA)
21.18
-0.12
(-0.56%)
USD |
NASDAQ |
Nov 22, 16:00
21.21
+0.03
(+0.14%)
After-Hours: 20:00
ADMA Biologics Profit Margin (Quarterly): 29.96% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 29.96% |
| June 30, 2024 | 29.91% |
| March 31, 2024 | 21.75% |
| December 31, 2023 | -23.88% |
| September 30, 2023 | 3.81% |
| June 30, 2023 | -10.60% |
| March 31, 2023 | -11.93% |
| December 31, 2022 | -24.47% |
| September 30, 2022 | -36.26% |
| June 30, 2022 | -40.60% |
| March 31, 2022 | -85.93% |
| December 31, 2021 | -63.11% |
| September 30, 2021 | -85.65% |
| June 30, 2021 | -106.0% |
| March 31, 2021 | -114.5% |
| December 31, 2020 | -139.1% |
| September 30, 2020 | -164.6% |
| June 30, 2020 | -259.1% |
| March 31, 2020 | -188.7% |
| December 31, 2019 | -87.74% |
| September 30, 2019 | -158.4% |
| June 30, 2019 | -201.4% |
| March 31, 2019 | -370.3% |
| December 31, 2018 | -444.7% |
| September 30, 2018 | -357.8% |
| Date | Value |
|---|---|
| June 30, 2018 | -316.7% |
| March 31, 2018 | -440.9% |
| December 31, 2017 | -108.2% |
| September 30, 2017 | -321.5% |
| June 30, 2017 | -265.8% |
| March 31, 2017 | -248.7% |
| December 31, 2016 | -137.0% |
| September 30, 2016 | -147.4% |
| June 30, 2016 | -264.7% |
| March 31, 2016 | -217.2% |
| December 31, 2015 | -182.4% |
| September 30, 2015 | -275.4% |
| June 30, 2015 | -357.2% |
| March 31, 2015 | -239.9% |
| December 31, 2014 | -239.4% |
| September 30, 2014 | -247.8% |
| June 30, 2014 | -264.0% |
| March 31, 2014 | -378.3% |
| December 31, 2013 | -1.11K% |
| September 30, 2013 | -242.8% |
| June 30, 2013 | -658.6% |
| March 31, 2013 | -408.8% |
| December 31, 2012 | -430.3% |
| September 30, 2012 | -900.8% |
| June 30, 2012 | -524.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-259.1%
Minimum
Jun 2020
29.96%
Maximum
Sep 2024
-67.84%
Average
-51.85%
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 25.86% |
| Madrigal Pharmaceuticals Inc | -172.0% |
| Assembly Biosciences Inc | -140.4% |
| TG Therapeutics Inc | 4.63% |
| Krystal Biotech Inc | 32.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 39.59% |
| Return on Assets | 18.97% |
| Return on Invested Capital | 22.77% |
| Gross Profit Margin (Quarterly) | 49.78% |
| Operating Margin (Quarterly) | 33.08% |
| Return on Net Operating Assets | 24.46% |